Wedge Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,186
Closed -$308K 511
2026
Q1
$308K Sell
3,186
-2,899
-48% -$297K 0.01% 497
2025
Q4
$646K Sell
6,085
-331
-5% -$38.4K 0.01% 464
2025
Q3
$815K Sell
6,416
-4,021
-39% -$479K 0.01% 452
2025
Q2
$1.28M Sell
10,437
-47,460
-82% -$5.42M 0.02% 396
2025
Q1
$5.86M Sell
57,897
-23,511
-29% -$2.3M 0.11% 186
2024
Q4
$7.52M Sell
81,408
-407
-0.5% -$40K 0.14% 166
2024
Q3
$7.91M Sell
81,815
-17,916
-18% -$1.61M 0.14% 170
2024
Q2
$8.56M Sell
99,731
-67,759
-40% -$5.69M 0.15% 154
2024
Q1
$13.8M Sell
167,490
-27,423
-14% -$2.01M 0.22% 123
2023
Q4
$13M Sell
194,913
-15,775
-7% -$1.02M 0.23% 112
2023
Q3
$14.1M Sell
210,688
-154,840
-42% -$10.7M 0.28% 105
2023
Q2
$24.7M Sell
365,528
-140,750
-28% -$8.82M 0.39% 90
2023
Q1
$27.4M Sell
506,278
-39,365
-7% -$2.29M 0.46% 85
2022
Q4
$32.6M Sell
545,643
-124,051
-19% -$6.75M 0.53% 73
2022
Q3
$30.3M Sell
669,694
-218,467
-25% -$10.9M 0.51% 82
2022
Q2
$39.6M Buy
888,161
+63,716
+8% +$3.27M 0.63% 36
2022
Q1
$46.6M Buy
824,445
+109,598
+15% +$5.72M 0.63% 39
2021
Q4
$37.1M Sell
714,847
-9,660
-1% -$498K 0.46% 73
2021
Q3
$43.3M Buy
724,507
+13,059
+2% +$822K 0.56% 41
2021
Q2
$44.2M Buy
711,448
+36,661
+5% +$2.44M 0.54% 50
2021
Q1
$44M Sell
674,787
-347,221
-34% -$22.6M 0.52% 54
2020
Q4
$67.2M Sell
1,022,008
-18,381
-2% -$1.08M 0.78% 41
2020
Q3
$53.8M Buy
1,040,389
+197,848
+23% +$10.2M 0.72% 40
2020
Q2
$41.5M Buy
842,541
+631,215
+299% +$34.1M 0.57% 57
2020
Q1
$10.8M Sell
211,326
-2,226
-1% -$128K 0.19% 156
2019
Q4
$11.8M Sell
213,552
-2,893
-1% -$157K 0.13% 213
2019
Q3
$10.9M Sell
216,445
-4,609
-2% -$232K 0.13% 212
2019
Q2
$11.1M Sell
221,054
-4,555
-2% -$221K 0.13% 212
2019
Q1
$10.5M Buy
225,609
+1,183
+0.5% +$59.9K 0.12% 217
2018
Q4
$11M Sell
224,426
-36,254
-14% -$2.06M 0.14% 212
2018
Q3
$16.2M Sell
260,680
-108,472
-29% -$6.6M 0.15% 190
2018
Q2
$19.9M Sell
369,152
-28,200
-7% -$1.41M 0.19% 141
2018
Q1
$18.1M Sell
397,352
-173,230
-30% -$7.43M 0.17% 151
2017
Q4
$22.4M Buy
570,582
+23,063
+4% +$877K 0.2% 142
2017
Q3
$20.2M Sell
547,519
-19,475
-3% -$694K 0.19% 156
2017
Q2
$21.8M Sell
566,994
-3,423
-0.6% -$125K 0.21% 150
2017
Q1
$19.4M Buy
570,417
+36,440
+7% +$1.2M 0.19% 147
2016
Q4
$17.5M Buy
533,977
+14,836
+3% +$481K 0.17% 174
2016
Q3
$16.8M Buy
519,141
+14,482
+3% +$469K 0.17% 163
2016
Q2
$15.6M Sell
504,659
-13,631
-3% -$426K 0.16% 173
2016
Q1
$15.5M Sell
518,290
-4,599
-0.9% -$127K 0.16% 174
2015
Q4
$14.5M Buy
522,889
+54,147
+12% +$1.54M 0.15% 185
2015
Q3
$14.3M Buy
468,742
+2,483
+0.5% +$86.4K 0.15% 187
2015
Q2
$17.1M Sell
466,259
-31,959
-6% -$1.14M 0.17% 168
2015
Q1
$17.6M Buy
498,218
+485,711
+3,884% +$16.6M 0.18% 160
2014
Q4
$383K Sell
12,507
-283
-2% -$8.82K ﹤0.01% 472
2014
Q3
$375K Buy
12,790
+1,791
+16% +$54.6K ﹤0.01% 478
2014
Q2
$314K Buy
10,999
+3,583
+48% +$99.9K ﹤0.01% 515
2014
Q1
$212K Sell
7,416
-283
-4% -$7.37K ﹤0.01% 485
2013
Q4
$204K Sell
7,699
-2,137
-22% -$59.5K ﹤0.01% 482
2013
Q3
$270K Buy
9,836
+126
+1% +$3.23K ﹤0.01% 433
2013
Q2
$222K Buy
+9,710
New +$219K ﹤0.01% 462

Other funds holding EHC

Wedge Capital Management's EHC Position: Q2 2026 in Review

Wedge Capital Management sold out of Encompass Health (EHC) in Q2 2026, closing a stake of 3,186 shares — an estimated $308K sold.

Wedge Capital Management first reported a position in EHC in Q2 2013 and held it in 52 quarters. The position peaked at $67.2M in Q4 2020. 54 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Wedge Capital Management reported no remaining Encompass Health position as of Q2 2026 after selling out during the quarter.
  • Wedge Capital Management sold 3,186 Encompass Health shares in Q2 2026, an estimated $308K.
  • Wedge Capital Management first reported a position in Encompass Health in Q2 2013 and held it in 52 quarters.
  • Wedge Capital Management's Encompass Health position peaked at $67.2M in Q4 2020.
  • 54 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.